×
About 17,598 results

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
https://clinicaltrials.gov/ct2/show/NCT00536796

Oct 29th, 2014 - A cholesterol/lipid profile screening project of high risk patients with hyperlipidaemia (secondary prevention) who already receive cholesterol-lowering therapy. Lipid profile and rate of patients who are treated to target (which is <100mg/dl for patients with high risk and <70mg/dl for patients at very high risk) are screened (hospital-based specialists). The doctors therapy decisions after th...

Safety and Efficacy of Multivessel Minimally Invasive Coronary Artery Bypass Graft Surgery
https://clinicaltrials.gov/ct2/show/NCT03247855

Aug 13th, 2017 - the aim of this study is to evaluate safety and efficacy of multivessel minimally invasive coronary artery bypass graft surgery through evaluating the possibility of reaching complete revascularization , the complications during surgery and the outcomes

Dietary Effects on Lipoproteins and Thrombogenic Activity (DELTA)
https://clinicaltrials.gov/ct2/show/NCT00000538

Aug 12th, 2014 - To evaluate the effects of carefully controlled diets on lipoproteins and clotting factors in different demographic groups.

Cardiac Rehabilitation in Patients With Refractory Angina
https://clinicaltrials.gov/ct2/show/NCT03218891

Jul 16th, 2017 - After signing the informed consent form, patients will be randomized into 4 groups: 1. Optimized clinical treatment group + physical training for 12 weeks (TF); 2. optimized clinical treatment group (CT); 3. Group with coronary insufficiency without angina (CD); Group 4: normal healthy subjects All patients will be submitted to the following procedures in 2 moments * (times 0 and 3): -Routine l...

Study of the Vascular Response to Percutaneous Coronary Intervention in Patients With Non-ST-elevation Acute Coronary Syndromes Using Intravascular Blood Sampling
https://clinicaltrials.gov/ct2/show/NCT03300167

Apr 19th, 2018 - This clinical protocol will be subject to peer review according to standard local procedures, including independent scientific review by the Scientific Advisory Board of the Clinical Research Facility, Sheffield Teaching Hospitals NHS Foundation Trust; the Clinical Research Office, Sheffield Teaching Hospitals NHS Foundation Trust; and the Research Ethics Committee. The study will be a single-c...

Computed Tomographic Coronary Angiography for Acute Chest Pain Evaluation
https://clinicaltrials.gov/ct2/show/NCT00615719

Dec 7th, 2011 - The acute coronary syndromes (ACS), which encompass unstable angina (UA) and both ST elevation and non-ST elevation myocardial infarction (STEMI and non-STEMI), are the leading cause of death in the United States. In addition, they account for a significant number of hospital admissions (300,000 per year for STEMI, >1,000,000 per year for non-ST elevation ACS). Differentiation of patients with ...

NGAL and Its Association With the No-reflow Phenomenon in ST-elevation Myocardial Infarction
https://clinicaltrials.gov/ct2/show/NCT03264859

Aug 28th, 2017 - Neutrophil Gelatinase-associated Lipocalin (NGAL) is a acute phase protein which is elevated in conditions like acute kidney injury and myocardial infarction. When a coronary artery is occluded, detrimental changes occur in myocardial vessels. After relief of the occlusion, blood flow to the heart may still be impeded, a phenomenon known as "no-reflow". Data is lacking on factors associated wit...

Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients With CSFP
https://clinicaltrials.gov/ct2/show/NCT03296670

Sep 27th, 2017 - The goal of STEMI therapy is to successfully restore epicardial blood flow. PCI has been documented as being the most effective method for restoration of epicardial blood flow. However, stenting does not necessarily equate to epicardial blood flow; not every patient achieves TIMI 3 flow after successful PCI. Currently, there are two main types of interventions to improve epicardial blood flow. ...

Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome
https://clinicaltrials.gov/ct2/show/NCT00968708

May 1st, 2014 - Alogliptin is a selective and potent dipeptidyl peptidase-4 inhibitor developed by Takeda for use in patients with type 2 diabetes mellitus. Cardiovascular outcomes is of special interest in the type 2 diabetes mellitus population, particularly in type 2 diabetes mellitus patients who have cardiovascular disease and are at high risk for major adverse cardiac events, such as those patients who h...

Efficacy and Safety Study of Binodenoson in Assessing Cardiac Ischemia
https://clinicaltrials.gov/ct2/show/NCT00944294

May 31st, 2012 - Binodenoson (an experimental drug) and adenosine (an FDA-approved drug that is currently used by doctors) are used to increase blood flow to the heart just like when a person exercises on a treadmill. Using imaging techniques, this increased blood flow can help determine if areas of the heart are not getting enough blood and oxygen during exercise. The purpose of the study is to determine if bi...

Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes
https://clinicaltrials.gov/ct2/show/NCT00191282

Jan 19th, 2011 - The purpose of this study is to evaluate the effect of two different treatment strategies on CV outcomes in patients with type 2 diabetes while aiming to achieve and maintain HbA1c <7.0% in both groups. Only patients who have recently experienced an acute MI will be considered for participation in this trial.

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries
https://clinicaltrials.gov/ct2/show/NCT00140101

Jan 9th, 2012 - Coronary artery disease is the major cause of morbidity and mortality in the United States. The American Heart Association estimates that 571,000 Percutaneous Transluminal Coronary Angioplasty (PTCA) procedures were performed in 2001 in the United States and that 80% to 90% of these patients also underwent stent placement. Despite the effectiveness of intracoronary stents in maintaining a large...

Effectiveness of Prehabilitation for Patients Undergoing Lumbar Spinal Stenosis Surgery
https://clinicaltrials.gov/ct2/show/NCT03388983

Jul 31st, 2018 - Lumbar spinal stenosis (LSS) is a common spinal disease that leads to pain and disability. LSS is defined as lower extremity and perineal symptoms (e.g. intermittent neurogenic claudication/numbness) that may occur with or without low back pain and that is attributed to congenital or acquired narrowing of space available for the neural and vascular tissues in the lumbar spine. Clinical symptoms...

Ciclosporin A and Acute Myocardial Infarction
https://clinicaltrials.gov/ct2/show/NCT00403728

Beyond its immunosuppressive properties, ciclosporine A (CsA) can also inhibit the opening of a mitochondrial mega-channel called the permeability transition pore (mPTP). Opening of the mPTP plays a key role in cardiomyocyte death during reperfusion following a prolonged ischemic insult. Ciclosporin A has been shown to reduce infarct size when administered at reperfusion in experimental models....

Evaluating the Association Between Pericardial Fat and Coronary Heart Disease - Ancillary to MESA
https://clinicaltrials.gov/ct2/show/NCT00402922

Jan 24th, 2017 - CHD is caused by a narrowing of the small blood vessels that supply blood and oxygen to the heart. It usually results from atherosclerosis, a condition in which deposits of fat, cholesterol, and other substances build up along the inner walls of arteries. Risk factors for CHD include tobacco use, high blood pressure, diabetes, and obesity. Visceral fat, the type of fat found in the abdomen and ...

The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)
https://clinicaltrials.gov/ct2/show/NCT00403338

Oct 6th, 2009 - Geographical miss has been associated with treatment failures after intracoronary radiation therapy. This phenomenon, which is secondary to vascular injury outside the treated segment, was strongly correlated with the development of restenosis at the edges of the treated coronary segment. The European and Canadian SIRIUS trials (E and C-SIRIUS) randomized 350 patients with similar baseline char...

MDCT of the Coronary Arteries in Heart Transplanted Patients
https://clinicaltrials.gov/ct2/show/NCT00403299

Jul 5th, 2011 - Heart transplanted patients (HTx) often develop coronary artery disease (CAD) which is a major cause of graft failure and death in this group of patients. Therefore, heart transplanted patients have their coronary arteries examined annually. At present this is being done with coronary angiography. Recent development of the computed tomography (CT) technology has made it possible to examine the ...

Clearance Of Mucus In Stents (COMIS)
https://clinicaltrials.gov/ct2/show/NCT01370278

Jul 2nd, 2018 - The goal of this clinical research study is to compare the effects of sodium bicarbonate to normal saline when used for clearing mucus blockage in patients with airway stents.

Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Patients With Acute Coronary Syndromes (The ATLAS ACS TIMI 46 Trial)
https://clinicaltrials.gov/ct2/show/NCT00402597

Oct 3rd, 2012 - This is a randomized (patients will be assigned to study treatment by chance), double-blind (neither the patient nor the study doctor will know the identity of the assigned study treatment) study to evaluate the safety and efficacy of rivaroxaban (study drug) compared to placebo (a tablet identical in appearance to study drug but contains no active drug) in patients with acute coronary syndrome...

Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis (ISAR-PEACE)
https://clinicaltrials.gov/ct2/show/NCT00402636

Nov 27th, 2007 - Coronary artery reblockage remains still a drawback of percutaneous coronary interventions even in the era of drug-eluting stents (DES). DESs working principle consists of the delivery of controlled amounts of antiproliferative agents at the local level, which results in the suppression of neontimal proliferation, the main cause of lumen re-narrowing after stent implantation. At present, severa...